Neuromuscular junction disorders Notes

Contents

Osmosis High-Yield Notes

This Osmosis High-Yield Note provides an overview of Neuromuscular junction disorders essentials. All Osmosis Notes are clearly laid-out and contain striking images, tables, and diagrams to help visual learners understand complex topics quickly and efficiently. Find more information about Neuromuscular junction disorders:

Lambert-Eaton myasthenic syndrome

Myasthenia gravis

NOTES NOTES NEUROMUSCULAR JUNCTION DISEASES GENERALLY, WHAT ARE THEY? PATHOLOGY & CAUSES ▪ Disorders impairing neuromuscular transmission lead to muscle fatigability, weakness CAUSES ▪ Autoantibody production ▫ Targeted against neuromuscular transmission pathway proteins ▪ Myasthenia gravis (MG) ▪ Lambert–Eaton myasthenic syndrome (LEMS) ▪ Transient acquired neonatal myasthenia ▪ Genetic mutation ▫ Affecting pathway components (e.g., congenital myasthenia) COMPLICATIONS ▪ Respiratory muscles involved → potentially fatal respiratory failure SIGNS & SYMPTOMS ▪ Primary clinical manifestation ▫ Painless muscle weakness without significant muscle atrophy ▫ Ocular, extraocular, oropharyngeal, bulbar, neck, limb, respiratory muscles DIAGNOSIS DIAGNOSTIC IMAGING CT scan ▪ Thymoma (MG) ▪ Small-cell lung carcinoma (LEMS) LAB RESULTS ▪ Serologic test for specific antibodies OTHER DIAGNOSTICS Electrophysiologic study ▪ Repetitive nerve stimulation ▫ Decremental response/improvement ▪ Electromyogram ▫ ↓ muscle action potential Pulmonary function test (PFT) ▪ Periodically ▫ Detect respiratory muscle involvement in forced vital capacity (FVC) ↓ TREATMENT ▪ Treat underlying cause (e.g. LEMS malignancy) MEDICATIONS ▪ Acetylcholinesterase inhibitors ▫ Inhibit acetylcholine degradation → ↑ acetylcholine concentration in neuromuscular junction (symptomatic therapy) ▪ Immunomodulating agents ▫ ↓ autoantibody production ▫ Individuals with poor acetylcholinesterase inhibitor response ▫ Corticosteroids/other immunosuppressive agents ▪ If above fails/emergency (e.g., myasthenic crisis) ▫ Plasmapheresis/intravenous immunoglobulin (IVIG) OSMOSIS.ORG 661
LAMBERT–EATON MYASTHENIC SYNDROME (LEMS) osms.it/lambert-eaton-myasthenic PATHOLOGY & CAUSES ▪ Rare autoimmune disorder ▫ Autoantibodies inhibit presynaptic calcium channels on motor neurons → reduced acetylcholine release in neuromuscular junction ▪ Muscle weakness ▫ Improves temporarily after repeated muscle use (no significant muscle atrophy) ▪ Mostly affects somatic nervous system, can also affect autonomic nervous system’s parasympathetic part ▪ Middle-aged adults (most cases) CAUSES Type II hypersensitivity reaction ▪ B cells produce antibodies that target, block voltage-gated calcium channels located presynaptically on motor neurons → only few unbound channels available to open, allow calcium in → ↓ calcium within neuron (insufficient to trigger acetylcholine release) → ↓ acetylcholine release in neuromuscular junction → attached muscle fiber does not contract ▪ Repeated stimulation by brain’s electrical impulses → enough calcium might get through remaining unbound calcium channels → acetylcholine release → muscle contraction RISK FACTORS ▪ Malignancy ▫ Strong small-cell lung cancer association; stimulus for antibody production is same calcium channel expression in neoplastic cells ▫ Other associated malignancies include 662 OSMOSIS.ORG lymphoproliferative disorders (e.g., Hodgkin’s lymphoma) ▪ Autoimmune diseases ▫ Hashimoto’s thyroiditis, diabetes mellitus type 1, vitiligo COMPLICATIONS ▪ Respiratory muscle involvement → respiratory failure ▪ Underlying malignancy → can lead to death SIGNS & SYMPTOMS ▪ Progressive, symmetrical proximal muscle weakness (e.g., shoulders, hips, thighs) → difficulty climbing stairs/standing when seated ▫ Paraneoplastic LEMS: more rapidly progressive course ▪ Warming-up phenomenon ▫ Repeated muscle use → weakness temporarily relieved ▪ Reflex strength ↓ ▫ Muscle activation → reflex recovery/ improvement ▪ Small minority ▫ Ocular, oropharyngeal muscle involvement ▪ Advanced stages ▫ Possible respiratory muscles involvement → respiratory failure (myasthenic crisis) ▪ Autonomic symptoms ▫ Dry mouth (most common), constipation, blurry vision, erectile dysfunction, urinary problems, syncope
Chapter 85 Neuromuscular Junction Disorders DIAGNOSIS DIAGNOSTIC IMAGING CT scan ▪ Chest ▫ Detect underlying small-cell lung cancer ▪ Abdomen, pelvis also recommended ▪ Negative initial malignancy evaluation ▫ Periodical screening recommended LAB RESULTS ▪ Serological tests ▫ Detect antibodies against the voltagegated calcium channels OTHER DIAGNOSTICS ▪ Electrophysiologic studies ▫ Repetitive nerve stimulation: ↑ muscle action potential amplitude ▫ Electromyogram: ↑ muscle action potential amplitude after exercise ▪ PFT ▫ ↓ FVC → respiratory muscle involvement TREATMENT MEDICATIONS ▪ Symptomatic therapy ▫ Acetylcholinesterase inhibitors: minimal effect ▫ Aminopyridines: block potassium channels → prolonged nerve membrane depolarization → ↑ calcium entry → ↑ acetylcholine release in neuromuscular junction ▪ If above methods fail ▫ Immunomodulating agents can be used (corticosteroids, other immunosuppressive agents) OTHER INTERVENTIONS ▪ Occasionally treated with IVIG/ plasmapheresis ▫ More severe cases MYASTHENIA GRAVIS osms.it/myasthenia-gravis PATHOLOGY & CAUSES ▪ Autoimmune disorder; significant skeletal muscle weakness ▫ Decreased acetylcholine receptor function → worsens with muscle use ▫ Most common neuromuscular junction disorder ▪ Type II hypersensitivity reaction ▫ B cells produce antibodies against postsynaptic nicotinic acetylcholine receptors of neuromuscular junction/ receptor-associated proteins ▫ Autoantibodies targeted against muscle-specific receptor tyrosine kinase ▪ ▪ ▪ ▪ (MuSK) → ↓ in acetylcholine receptor function Acetylcholine cannot bind → normal action potentials cannot be generated (adjacent muscle Complement activated → inflammatory response initiation → postsynaptic membrane damage → acetylcholine receptor destruction Bimodal onset age ▫ 20–30 years old (biologically-female predominance) ▫ 60–70 years old (biologically-male predominance) Associated with thymic abnormality; thymus considered antigen source OSMOSIS.ORG 663
promoting autoantibody production (most cases) ▪ Neonatal myasthenia gravis ▫ Transient myasthenia form (newborn from individual with myasthenia gravis) ▫ Maternal antibodies → transplacental passage → neuromuscular junction function interference ▪ Rare non-immune mediated forms ▫ E.g. congenital myasthenia gravis ▫ Mutations affecting neuromuscular transmission COMPLICATIONS ▪ Myasthenic crisis ▫ Decreased respiratory muscle function → life-threatening respiratory failure (requires mechanical ventilation) ▫ Occurs spontaneously/precipitated (e.g. surgery, infection, medication, immunosuppressive-agent withdrawal) SIGNS & SYMPTOMS ▪ Fluctuating muscle weakness ▫ Exacerbated by repetitive muscle use throughout day/after exertion/repetitive movement ▪ Improves with rest ▪ Progression ▫ Symptoms continuously present, fluctuate from mild–severe ▪ Sensation, reflexes preserved Clinical MG forms ▪ Ocular myasthenia ▫ Limited (eyelid, extraocular muscle); individuals (50%) with ocular myasthenia will → generalized myasthenia (< two years) ▪ Generalized myasthenia ▫ Ocular, bulbar, facial, limb, respiratory muscle ▪ Ocular muscles ▫ Eyelid (ptosis), extraocular (binocular diplopia) ▪ Bulbar muscle ▫ Jaw closure (prolonged chewing → weakness), oropharyngeal (dysarthria, 664 OSMOSIS.ORG ▪ ▪ ▪ ▪ dysphagia), palatal (nasal tone, prolonged speech → hypophonia) Facial muscle ▫ Facial weakness, facial expression loss Neck muscle ▫ Cannot keep head up (“drooped head syndrome”) Limb muscle ▫ Proximal, asymmetric muscle weakness Respiratory muscle ▫ Respiratory failure (myasthenic crisis) DIAGNOSIS DIAGNOSTIC IMAGING CT scan ▪ Chest scan to detect associated thymic abnormalities ▫ Abnormal thymus (most cases) ▫ Thymoma LAB RESULTS ▪ Serologic test ▫ Acetylcholine receptor antibodies (AChR-Abs)/muscle-specific receptor tyrosine kinase antibodies (MuSK-Abs) ▫ Most specific tests ▫ Seronegative for AChR-Abs, MuSK-Abs OTHER DIAGNOSTICS ▪ Electrophysiologic studies ▫ Repetitive nerve stimulation studies: progressive decline in muscle action potential amplitude (decremental response) ▫ Single-fiber electromyography: increased jitter ▪ Tensilon test ▫ Edrophonium: acetylcholinesterase inhibitor with rapid onset, short acting duration ▫ Prolongs acetylcholine presence in neuromuscular junction → marked improvement ▫ Easy to perform/limited utility; high false-positive rate, possible complications from muscarinic effects
Chapter 85 Neuromuscular Junction Disorders (especially older adults, e.g. bradycardia, bronchospasm) ▪ PFTs ▫ Periodical FVC monitoring; FVC ↓ reveals respiratory muscle involvement ▪ Ice pack test ▫ Ice pack application (2–5 minutes) → MG-affected muscles ▫ Neuromuscular transmission improvement in low temperature SURGERY ▪ Thymectomy, especially for thymoma; myasthenia often improves/disappears ▪ Rapidly worsening myasthenia/myasthenic crisis ▫ Intubation ▫ Plasmapheresis/intravenous immunoglobulin (IVIG) ▫ Long-acting immunotherapy (e.g., corticosteroids, azathioprine) MNEMONIC Edrophonium vs. pyridostigmine eDrophonium for Diagnosis pyRIDostigmine is to get RID of symptoms Figure 85.1 A biologically-female individual with myasthenia gravis demonstrating ptosis of the right eye before treatment (above) and after treatment (below) with edrophonium. TREATMENT ▪ No curative method MEDICATIONS ▪ Avoid MG-exacerbating drugs (e.g. aminoglycosides, tetracyclines, betablockers, quinidine) ▪ Acetylcholinesterase inhibitors ▫ Symptomatic therapy ▪ Immunomodulating agents ↓ autoantibody production ▫ Individuals with poor acetylcholinesterase inhibitor response ▪ Corticosteroids, other immunosuppressive agents OSMOSIS.ORG 665

Osmosis High-Yield Notes

This Osmosis High-Yield Note provides an overview of Neuromuscular junction disorders essentials. All Osmosis Notes are clearly laid-out and contain striking images, tables, and diagrams to help visual learners understand complex topics quickly and efficiently. Find more information about Neuromuscular junction disorders by visiting the associated Learn Page.